Is long-term acyclovir use safe?
Acyclovir, an antiviral for herpes simplex virus (HSV) and varicella-zoster virus (VZV), is generally safe for extended periods in appropriate patients, but safety depends on dose, duration, kidney function, and monitoring. Studies show continuous suppressive therapy—often 400 mg twice daily for 6–12 months or longer—is well-tolerated for recurrent genital herpes, with low discontinuation rates due to adverse events (around 2–5%).[1][2] Long-term use up to several years occurs in immunocompromised patients or those with frequent outbreaks, without major toxicity when adjusted for renal clearance.
What are the main risks with prolonged use?
Kidney issues top the list: acyclovir can cause acute kidney injury from crystal formation in tubules, especially at high doses (>1 g/day IV) or with dehydration. Risk rises with preexisting renal disease; guidelines recommend dose cuts (e.g., 200–400 mg 2–5 times daily for CrCl <10 mL/min) and hydration.[3][4] Other effects include:
- Mild GI upset (nausea, diarrhea) in 5–10% of users.
- Rare neurotoxicity (confusion, tremors), mostly in elderly or renal-impaired patients on IV therapy.
- Minimal hematologic changes; no strong cancer or fertility risks in human data.
Resistance develops in 5% of immunocompetent patients after 1–2 years of suppression, higher (up to 30%) in immunocompromised.[5]
How do doctors monitor patients on long-term acyclovir?
Routine checks include serum creatinine every 3–6 months, or more often if renal risks exist. Liver enzymes and blood counts are optional unless symptoms arise. Stop therapy periodically (e.g., every 12 months) to assess need, as natural outbreak frequency may decline.[1][6] IV users need closer IV fluid management.
Who should avoid or limit long-term use?
Avoid in severe renal failure without adjustment. Use caution in elderly, dehydrated patients, or those on nephrotoxic drugs (e.g., NSAIDs, aminoglycosides). Not recommended long-term in pregnancy unless benefits outweigh risks (Category B; safe in short bursts).[4] Breastfeeding is okay at standard doses, as levels in milk are low.
What do real-world studies show for years-long use?
Trials like the 1-year suppression study (n=774) reported adverse events similar to placebo, with renal issues in <1%.[2] Five-year data in HIV patients showed good tolerance but rising resistance.[5] No large-scale mortality signals from extended oral use.
Alternatives for chronic herpes suppression?
Valacyclovir (1 g daily) or famciclovir offer similar efficacy with easier dosing and lower resistance risk in some cases. Foscarnet or cidofovir for resistant strains, but they're more toxic.[6]
[1]: CDC STI Treatment Guidelines
[2]: Spruance et al., Antimicrob Agents Chemother (2003)
[3]: Lexicomp Acyclovir Monograph
[4]: UpToDate: Acyclovir overview
[5]: Bacon et al., J Infect Dis (2003)
[6]: AAFP Herpes Management